CAN
Claraphi Advisory Network’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $755K | Buy |
14,736
+4,105
| +39% | +$210K | 0.3% | 94 |
|
|
2022
Q3 | $465K | Sell |
10,631
-10,070
| -49% | -$440K | 0.25% | 110 |
|
|
2022
Q2 | $1.09M | Buy |
20,701
+234
| +1% | +$12.3K | 0.38% | 61 |
|
|
2022
Q1 | $1.06M | Sell |
20,467
-526
| -3% | -$27.2K | 0.31% | 67 |
|
|
2021
Q4 | $1.24M | Buy |
20,993
+6,056
| +41% | +$358K | 0.43% | 53 |
|
|
2021
Q3 | $642K | Buy |
14,937
+575
| +4% | +$24.7K | 0.23% | 107 |
|
|
2021
Q2 | $562K | Buy |
14,362
+133
| +0.9% | +$5.2K | 0.17% | 141 |
|
|
2021
Q1 | $516K | Sell |
14,229
-5,564
| -28% | -$202K | 0.14% | 153 |
|
|
2020
Q4 | $729K | Sell |
19,793
-11,497
| -37% | -$423K | 0.2% | 108 |
|
|
2020
Q3 | $1.15M | Buy |
31,290
+19,231
| +159% | +$706K | 0.42% | 41 |
|
|
2020
Q2 | $394K | Sell |
12,059
-290
| -2% | -$9.48K | 0.17% | 129 |
|
|
2020
Q1 | $403K | Buy |
12,349
+600
| +5% | +$19.6K | 0.19% | 103 |
|
|
2019
Q4 | $460K | Sell |
11,749
-1,784
| -13% | -$69.8K | 0.28% | 83 |
|
|
2019
Q3 | $486K | Buy |
13,533
+203
| +2% | +$7.29K | 0.29% | 74 |
|
|
2019
Q2 | $576K | Buy |
13,330
+967
| +8% | +$41.8K | 0.34% | 71 |
|
|
2019
Q1 | $524K | Sell |
12,363
-320
| -3% | -$13.6K | 0.33% | 73 |
|
|
2018
Q4 | $554K | Sell |
12,683
-10,201
| -45% | -$446K | 0.42% | 62 |
|
|
2018
Q3 | $1.01M | Sell |
22,884
-747
| -3% | -$32.9K | 0.56% | 40 |
|
|
2018
Q2 | $857K | Buy |
23,631
+936
| +4% | +$33.9K | 0.55% | 45 |
|
|
2018
Q1 | $805K | Buy |
22,695
+4,676
| +26% | +$166K | 0.57% | 44 |
|
|
2017
Q4 | $653K | Buy |
+18,019
| New | +$653K | 0.51% | 57 |
|